Breaking-Serum Institute of India has submitted the data of Covishield Vaccine trials to DGCI

The Serum Institute of India (SII) has submitted the data to DCGI’s Subject Expert Committee (SEC).In previous meeting by SEC Serum Institute of India and bharat biotech was asked to submit more data about clinical trials, reports IANS

The SEC can do a meeting on Serum Institute of India’s emergency authorisation for Covishield vaccine at the end of this week.

Recommended For You